Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 21, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, June 20, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Louise Chen Reiterated (ATOS) at Buy on, Jun 20th, 2024
Published on 2024-10-28 12:01:33 - WOPRAI, Louise Chen
Louise Chen of Cantor Fitzgerald, Reiterated "Atossa Therapeutics, Inc." (ATOS) at Buy on, Jun 20th, 2024.
Louise has made no other calls on ATOS in the last 4 months.
There are 2 other peers that have a rating on ATOS. Out of the 2 peers that are also analyzing ATOS, 0 agree with Louise's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Louise
- Edward Woo of "Ascendiant Capital" Maintained at Strong Buy with Increased Target to $6.25 on, Thursday, June 6th, 2024
- Emily Bodnar of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Monday, May 13th, 2024
